Dean H. Stanton · Selected Work

Patent, Trademark & Intellectual-Property Portfolio Governance

Executive intellectual-property governance integrated with product development and commercialization, including patent-filing coordination, trademark management, licensing, attorney coordination, infringement support, and patent-marking controls.

Results

Results and contributions.

01>20 USPTO filingsManaged more than 20 USPTO patent filings by 2017.

Filing count, rather than granted patents or inventor credits.

02Trademark cancellationOn November 3, 2011, outside counsel reported that the Trademark Trial and Appeal Board had granted PPI's request to cancel a competing EzySplint registration.
03Integrated IP managementConnected patents, trademarks, licensing, product marking, and attorney coordination to the company's product-development and commercialization work.
01
Situation

Operating context

PPI needed to convert product innovation, brand identity, partnerships, and proprietary designs into controlled intellectual-property assets while coordinating ownership, protection, licensing, commercialization rights, and infringement risk.

02
Challenge

What made the work difficult

Product development and commercialization depended on coordinating patent filings, trademarks, licensing rights, product marking, and infringement response across company teams, inventors, and outside counsel.

03
Dean's role

Responsibility and authority

Dean managed patent-application coordination, trademarks, licensing, infringement support, and product marking as part of his engineering and executive responsibilities. He coordinated company priorities and supporting evidence with outside counsel, who handled legal representation and filings.

04
Actions

How the work moved forward

  1. Integrated patent and trademark management with product-development and commercialization workflows.
  2. Coordinated patent-application and prosecution support, trademarks, licensing, and attorney interaction.
  3. Directed patent-number and patent-pending marking across product literature and packaging.
  4. Coordinated company evidence and operating decisions for infringement and brand-defense matters.